Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib.
Akimitsu MaedaHitoshi AndoNobuyuki KatakamiNaoya HashimotoJun-Ichi MorishigeShoji FukushimaAkira OkadaHiromichi EbiMasahide MatsuzakiHiroji IwataMasataka SawakiPublished in: European journal of clinical pharmacology (2022)
ABCB1 2677G > T/A polymorphism might be a predictor of the pharmacokinetics and tolerability of abemaciclib.